Related Experiment Video
Updated: Jul 21, 2025
09:15
Inducing and Characterizing Vesicular Steatosis in Differentiated HepaRG Cells
Published on: July 18, 2019
8.9K
Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis
Olfa Khalifa1, Khalid Ouararhni2, Khaoula Errafii3
1Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha P.O. Box 34110, Qatar.
International Journal of Molecular Sciences
|July 29, 2023
Summary
Glucagon-like peptide-1 receptor agonists like exendin-4 may help reduce liver fat in non-alcoholic fatty liver disease by altering microRNA expression. This suggests new therapeutic pathways for fatty liver conditions.
Area of Science:
- Hepatology and Molecular Biology
- Endocrinology and Metabolism
Background:
- Non-alcoholic fatty liver disease (NAFLD) is characterized by excess hepatic lipid accumulation, with no approved medications.
- Glucagon-like peptide-1 receptor agonists (GLP-1RAs), used for type 2 diabetes, show potential for NAFLD treatment.
Purpose of the Study:
- To investigate the effect of the GLP-1RA exendin-4 (Ex-4) on microRNA (miRNA) expression in an in vitro model of hepatic steatosis.
- To identify signaling pathways and cellular functions modulated by Ex-4 through miRNA expression changes.
Main Methods:
- Utilized an in vitro steatosis model with control, steatotic, and Ex-4-treated steatotic cells.
- Isolated total RNA, including miRNAs, and analyzed expression profiles of 799 miRNAs using NanoString technology.
- Performed enrichment pathway analysis on differentially expressed miRNAs.
Main Results:
- Exendin-4 treatment reversed the expression of a specific set of microRNAs in steatotic liver cells.
- Enrichment analysis revealed significant modulation of pathways including hepatic fibrosis, insulin receptor, PPAR, Wnt/β-Catenin, VEGF, and mTOR signaling.
- Affected cellular functions included liver fibrosis, cirrhosis, hepatic stellate cell proliferation, and glucose metabolism.
Conclusions:
- MicroRNAs are implicated in the steatosis-reducing effects of GLP-1 receptor agonists.
- These findings support further investigation into the role of miRNAs in NAFLD treatment with GLP-1RAs.
Related Concept Videos
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:58Cell Specific Gene Expression
13.6K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K